For an administration that promises to pull back regulations, CVS Health's (CVS) plan to buy Aetna (AET) for some $69 billion will be a big test for the government, according to TD Ameritrade's chief market analyst JJ Kinahan. 

Kinahan expects this deal to benefit consumers.

More of What's Trending on TheStreet:

 

More from Video

I Hire the People Who Are Smarter Than I Am, Says Alibaba's Jack Ma

I Hire the People Who Are Smarter Than I Am, Says Alibaba's Jack Ma

Will 2019 Make IPO's Great Again?

Will 2019 Make IPO's Great Again?

Oracle Taking a 'Holistic' Approach to the Cloud

Oracle Taking a 'Holistic' Approach to the Cloud

Davos 2019: Salesforce Co-CEO Reveals What Keeps him Up at Night

Davos 2019: Salesforce Co-CEO Reveals What Keeps him Up at Night

Market Movers: January FOMC Meeting

Market Movers: January FOMC Meeting